$GLAND shares surged as much as 9.8% in morning trade on August 11, 2026, hitting their highest level in four years after the company reported a strong set of Q1 numbers. 📈 Q1 FY27 Highlights (Consolidated YoY): • Net Profit: ₹317 crore, up 47.1% from ₹215.5 crore • Revenue: ₹1,800.3 crore, up 19.6% from ₹1,505.6 crore The sharp jump in profitability, coupled with healthy revenue growth, has boosted investor confidence and fueled strong buying interest in the stock. Today's rally underscores the market’s positive reaction to GLAND Pharma’s impressive operational performance and earnings momentum. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

#StockInNews#WatchOutFor

1,048 likes·52 comments